TOX3 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "TOX3" in English language version.

Last modified: 18:10:25, 13 November 2025 (UTC)

Ref.Un. Ref.Website

Global rank English rank

2816nih.gov

5^th place

169doi.org

2^nd place

52adsabs.harvard.edu

14^th place

9^th place

32semanticscholar.org

15^th place

8^th place

11atlasgeneticsoncology.org

low place

11omim.org

3,900^th place

3,720^th place

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. (June 2007). "Genome-wide association study identifies novel breast cancer susceptibility loci". Nature. 447 (7148): 1087–93. Bibcode:2007Natur.447.1087E. doi:10.1038/nature05887. PMC 2714974. PMID 17529967.
Jones JO, Chin SF, Wong-Taylor LA, Leaford D, Ponder BA, Caldas C, Maia AT (2013). "TOX3 mutations in breast cancer". PLOS ONE. 8 (9) e74102. Bibcode:2013PLoSO...874102J. doi:10.1371/journal.pone.0074102. PMC 3777980. PMID 24069272.

atlasgeneticsoncology.org (Global: low place; English: low place)

"TOX3 (TOX high mobility group box family member 3)". Atlas of Genetics and Cytogenetics in Oncology and Haematology.

doi.org (Global: 2^nd place; English: 2^nd place)

Smid M, Wang Y, Klijn JG, Sieuwerts AM, Zhang Y, Atkins D, et al. (May 2006). "Genes associated with breast cancer metastatic to bone". Journal of Clinical Oncology. 24 (15): 2261–7. doi:10.1200/JCO.2005.03.8802. PMID 16636340.
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. (June 2007). "Genome-wide association study identifies novel breast cancer susceptibility loci". Nature. 447 (7148): 1087–93. Bibcode:2007Natur.447.1087E. doi:10.1038/nature05887. PMC 2714974. PMID 17529967.
O'Flaherty E, Kaye J (April 2003). "TOX defines a conserved subfamily of HMG-box proteins". BMC Genomics. 4 (1) 13. doi:10.1186/1471-2164-4-13. PMC 155677. PMID 12697058.
Jones JO, Chin SF, Wong-Taylor LA, Leaford D, Ponder BA, Caldas C, Maia AT (2013). "TOX3 mutations in breast cancer". PLOS ONE. 8 (9) e74102. Bibcode:2013PLoSO...874102J. doi:10.1371/journal.pone.0074102. PMC 3777980. PMID 24069272.
Gudmundsdottir ET, Barkardottir RB, Arason A, Gunnarsson H, Amundadottir LT, Agnarsson BA, et al. (December 2012). "The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients". BMC Cancer. 12 621. doi:10.1186/1471-2407-12-621. PMC 3553017. PMID 23270421.
Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. (July 2007). "Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer". Nature Genetics. 39 (7): 865–9. doi:10.1038/ng2064. PMID 17529974. S2CID 7346190.
Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, et al. (April 2008). "Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers". American Journal of Human Genetics. 82 (4): 937–48. doi:10.1016/j.ajhg.2008.02.008. PMC 2427217. PMID 18355772.
Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M (June 2010). "Genetic susceptibility to breast cancer". Molecular Oncology. 4 (3): 174–91. doi:10.1016/j.molonc.2010.04.011. PMC 5527934. PMID 20542480.
Jiang B, Chen W, Qin H, Diao W, Li B, Cao W, et al. (May 2019). "TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma". Cancer Letters. 449: 76–86. doi:10.1016/j.canlet.2019.02.020. PMID 30772441. S2CID 73487599.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Smid M, Wang Y, Klijn JG, Sieuwerts AM, Zhang Y, Atkins D, et al. (May 2006). "Genes associated with breast cancer metastatic to bone". Journal of Clinical Oncology. 24 (15): 2261–7. doi:10.1200/JCO.2005.03.8802. PMID 16636340.
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. (June 2007). "Genome-wide association study identifies novel breast cancer susceptibility loci". Nature. 447 (7148): 1087–93. Bibcode:2007Natur.447.1087E. doi:10.1038/nature05887. PMC 2714974. PMID 17529967.
O'Flaherty E, Kaye J (April 2003). "TOX defines a conserved subfamily of HMG-box proteins". BMC Genomics. 4 (1) 13. doi:10.1186/1471-2164-4-13. PMC 155677. PMID 12697058.
Jones JO, Chin SF, Wong-Taylor LA, Leaford D, Ponder BA, Caldas C, Maia AT (2013). "TOX3 mutations in breast cancer". PLOS ONE. 8 (9) e74102. Bibcode:2013PLoSO...874102J. doi:10.1371/journal.pone.0074102. PMC 3777980. PMID 24069272.
Gudmundsdottir ET, Barkardottir RB, Arason A, Gunnarsson H, Amundadottir LT, Agnarsson BA, et al. (December 2012). "The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients". BMC Cancer. 12 621. doi:10.1186/1471-2407-12-621. PMC 3553017. PMID 23270421.
Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. (July 2007). "Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer". Nature Genetics. 39 (7): 865–9. doi:10.1038/ng2064. PMID 17529974. S2CID 7346190.
Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, et al. (April 2008). "Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers". American Journal of Human Genetics. 82 (4): 937–48. doi:10.1016/j.ajhg.2008.02.008. PMC 2427217. PMID 18355772.
Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M (June 2010). "Genetic susceptibility to breast cancer". Molecular Oncology. 4 (3): 174–91. doi:10.1016/j.molonc.2010.04.011. PMC 5527934. PMID 20542480.
Jiang B, Chen W, Qin H, Diao W, Li B, Cao W, et al. (May 2019). "TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma". Cancer Letters. 449: 76–86. doi:10.1016/j.canlet.2019.02.020. PMID 30772441. S2CID 73487599.

ncbi.nlm.nih.gov

Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. (June 2007). "Genome-wide association study identifies novel breast cancer susceptibility loci". Nature. 447 (7148): 1087–93. Bibcode:2007Natur.447.1087E. doi:10.1038/nature05887. PMC 2714974. PMID 17529967.
O'Flaherty E, Kaye J (April 2003). "TOX defines a conserved subfamily of HMG-box proteins". BMC Genomics. 4 (1) 13. doi:10.1186/1471-2164-4-13. PMC 155677. PMID 12697058.
"TOX3 TOX high mobility group box family member 3 [Homo sapiens (human)]". Gene - NCBI. National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine.
Jones JO, Chin SF, Wong-Taylor LA, Leaford D, Ponder BA, Caldas C, Maia AT (2013). "TOX3 mutations in breast cancer". PLOS ONE. 8 (9) e74102. Bibcode:2013PLoSO...874102J. doi:10.1371/journal.pone.0074102. PMC 3777980. PMID 24069272.
Gudmundsdottir ET, Barkardottir RB, Arason A, Gunnarsson H, Amundadottir LT, Agnarsson BA, et al. (December 2012). "The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients". BMC Cancer. 12 621. doi:10.1186/1471-2407-12-621. PMC 3553017. PMID 23270421.
Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, et al. (April 2008). "Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers". American Journal of Human Genetics. 82 (4): 937–48. doi:10.1016/j.ajhg.2008.02.008. PMC 2427217. PMID 18355772.
Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M (June 2010). "Genetic susceptibility to breast cancer". Molecular Oncology. 4 (3): 174–91. doi:10.1016/j.molonc.2010.04.011. PMC 5527934. PMID 20542480.

omim.org (Global: 3,900^th place; English: 3,720^th place)

"OMIM Entry - * 611416 - TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3; TOX3". Online Mendelian Inheritance in Man (OMIM).

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. (July 2007). "Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer". Nature Genetics. 39 (7): 865–9. doi:10.1038/ng2064. PMID 17529974. S2CID 7346190.
Jiang B, Chen W, Qin H, Diao W, Li B, Cao W, et al. (May 2019). "TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma". Cancer Letters. 449: 76–86. doi:10.1016/j.canlet.2019.02.020. PMID 30772441. S2CID 73487599.

TOX3 (English Wikipedia)

adsabs.harvard.edu (Global: 14th place; English: 9th place)